Related Experiment Video
Updated: Aug 9, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy?
Shiao Li Oei1, Friedemann Schad1,2
1Network Oncology, Research Institute Havelhöhe, Kladower Damm 221, 14089 Berlin, Germany.
Abstract:
Numerous clinical studies have been conducted to improve the outcomes of patients suffering from pancreatic cancer. Different approaches using targeted therapeutic strategies and precision medicine methods have been investigated, and synergies and further therapeutic advances may be achieved through combinations with integrative methods. For pancreatic tumors, a particular challenge is the presence of a microenvironment and a dense stroma, which is both a physical barrier to drug penetration and a complex entity being controlled by the immune system. Therefore, the state of immunological tolerance in the tumor microenvironment must be overcome, which is a considerable challenge. Integrative approaches, such as hyperthermia, percutaneous irreversible electroporation, intra-tumoral injections, phytotherapeutics, or vitamins, in combination with standard-oncological therapies, may potentially contribute to the control of pancreatic cancer. The combined application of standard-oncological and integrative methods is currently being studied in ongoing clinical trials. An actual overview is given here.
Insights
This study explores combining standard cancer treatments with integrative methods like hyperthermia and phytotherapeutics to overcome pancreatic cancer's challenges. Clinical trials are investigating these novel combinations for better patient outcomes.
Area of Science:
- Oncology
- Integrative Medicine
Background:
- Pancreatic cancer presents significant treatment challenges due to its dense stroma and immune-suppressive tumor microenvironment.
- The tumor microenvironment acts as a physical barrier to drug delivery and involves complex immune system interactions.
- Overcoming immunological tolerance within the tumor microenvironment is crucial for effective pancreatic cancer therapy.
Purpose of the Study:
- To provide an overview of current clinical studies investigating the combination of standard oncological therapies with integrative methods for pancreatic cancer.
- To explore the potential of integrative approaches in overcoming the challenges posed by the pancreatic tumor microenvironment.
Main Methods:
- Review of clinical studies and ongoing trials focusing on pancreatic cancer treatment.
- Investigation of targeted therapeutic strategies, precision medicine, and combination therapies.
- Analysis of integrative methods including hyperthermia, percutaneous irreversible electroporation, intra-tumoral injections, phytotherapeutics, and vitamins.
Main Results:
- Combination therapies involving standard treatments and integrative methods are under active investigation in clinical trials.
- Integrative approaches show potential in addressing the physical and immunological barriers of the pancreatic tumor microenvironment.
- Synergistic effects and therapeutic advances may be achieved by combining different treatment modalities.
Conclusions:
- Combining standard oncological therapies with integrative methods offers a promising strategy for managing pancreatic cancer.
- Further clinical research is essential to validate the efficacy and safety of these combined approaches.
- Addressing the tumor microenvironment and overcoming immune tolerance are key to improving pancreatic cancer treatment outcomes.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

